In the present study conducted in the same study site/hospital (March 2024–February 2025), 64% of suspected cases examined were diagnosed as leptospirosis by PCR or IgM ELISA (PCR-positive rate, 29.1%). The gene discussed is CD40LG; the disease is leptospirosis.